Balaxi Pharmaceuticals

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue74.5868.9657.7772.6473.63
Expenses64.9168.0756.3871.0372.23
EBITDA10.862.372.753.193.04
Operating Profit10.401.912.272.632.39
Profit Before Tax9.670.901.381.611.40
Net Profit8.640.290.210.310.61
Financial Ratios
Operating Profit Margin14.24%3.35%4.89%4.40%4.30%
Net Profit Margin11.33%0.41%0.37%0.43%0.86%
Earning Per Share (Diluted)1.560.050.040.060.11
Dividends Per Share0.000.000.000.000.00